Safety and Pharmacokinetics Study of MBX 2109 in Adult Subjects With Normal and Impaired Renal Function

Clinical trial NCT06496217 · COMPLETED

Trial details

NCT number: NCT06496217
Sponsor: MBX Biosciences
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Renal Impairment

Start date: 2024-06-13
Primary completion: 2025-09-04
Enrollment: 25

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.